Blood test may allow safer radiation for throat cancer

NCT ID NCT05962242

Recruiting now Disease control Sponsor: University of Virginia Source: ClinicalTrials.gov ↗

First seen Feb 05, 2026 · Last updated Jun 16, 2026 · Updated 25 times

Summary

This study tests whether a lower dose of radiation to the neck can safely control head and neck cancer. About 90 adults with oropharynx cancer will receive radiation guided by a blood test that tracks HPV DNA from the tumor. The goal is to reduce side effects while keeping the cancer under control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bon Secours
NOT_YET_RECRUITING

Richmond, Virginia, 23114, United States

Contact
Eastern Virginia Medical School
NOT_YET_RECRUITING

Norfolk, Virginia, 23507, United States

Contact
Miami Cancer Institute
RECRUITING

Miami, Florida, 33176, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
University of Virginia
RECRUITING

Charlottesville, Virginia, 22908, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Virginia Commonwealth University
RECRUITING

Richmond, Virginia, 23284, United States

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX